Raman Bahal
Associate Professor/Pharmaceutical Science
Storrs Mansfield
Are you Raman Bahal?
How to update your information.
Scholarly Contributions
69 Scholarly Contributions
PLA-HPG particles delivered multiple oncomiRs inhibitors for cancer treatment
2021
Research Type: Patent and Intellectual Property
Ontogenic mRNA expression of RNA modification writers, erasers, and readers in mouse liver.
2019
Research Type: Journal Article
Next-generation poly-L-histidine formulations for miRNA mimic delivery
2023
Research Type: Journal Article
Next generation microRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticle
2020
Research Type: Patent and Intellectual Property
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.
2020
Research Type: Journal Article
New Technologies Bloom Together for Bettering Cancer Drug Conjugates.
2022
Research Type: Journal Article
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies
2022
Research Type: Other Scholarly Work
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium.
2015
Research Type: Journal Article
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.
2019
Research Type: Journal Article
Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids.
2022
Research Type: Journal Article
Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.
2013
Research Type: Journal Article
Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes
2023
Research Type: Journal Article
Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.
2015
Research Type: Journal Article